nsclc

Series: Research To Practice | Oncology Videos

Episode: Lung Cancer | Geoffrey R Oxnard, MD

Duration: 10 min

Thu Apr 30 2020

Series: PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast

Episode: Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment: Latest Evidence and Practical Guidance in the Context of a Changing Targeted Therapy Landscape

Duration: 1 hr 2 min

Mon Jun 08 2020

Series: PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast

Episode: Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment: Latest Evidence and Practical Guidance in the Context of a Changing Targeted Therapy Landscape

Duration: 1 hr 2 min

Mon Jun 08 2020

Series: PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Episode: Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment: Latest Evidence and Practical Guidance in the Context of a Changing Targeted Therapy Landscape

Duration: 1 hr 2 min

Mon Jun 08 2020

Series: PeerView Clinical Pharmacology CME/CNE/CPE Video

Episode: Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment: Latest Evidence and Practical Guidance in the Context of a Changing Targeted Therapy Landscape

Duration: 1 hr 2 min

Mon Jun 08 2020

Series: PeerView Internal Medicine CME/CNE/CPE Audio Podcast

Episode: Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment: Latest Evidence and Practical Guidance in the Context of a Changing Targeted Therapy Landscape

Duration: 1 hr 2 min

Mon Jun 08 2020

Series: ReachMD CME

Episode: Adjuvant Treatment of Early Non–Small Cell Lung Cancer in the Era of Immunotherapy

4 months ago

Series: PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

Episode: Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment: Latest Evidence and Practical Guidance in the Context of a Changing Targeted Therapy Landscape

Duration: 1 hr 2 min

Mon Jun 08 2020

Series: QuadShot News Podcast

Episode: 5.2.2022 - Segmented

Duration: 13 min

3 months ago

Series: PeerView Internal Medicine CME/CNE/CPE Video Podcast

Episode: Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment: Latest Evidence and Practical Guidance in the Context of a Changing Targeted Therapy Landscape

Duration: 1 hr 2 min

Mon Jun 08 2020

Series: PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

Episode: Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment: Latest Evidence and Practical Guidance in the Context of a Changing Targeted Therapy Landscape

Duration: 1 hr 2 min

Mon Jun 08 2020

Series: Research To Practice | Oncology Videos

Episode: Non-Small Cell Lung Cancer | Proceedings from Our Targeted Therapy for NSCLC Webinar

Duration: 1 hr 2 min

6 months ago

Series: GRACEcast Lung Cancer Audio

Episode: Chemotherapy for Second Line Treatment of Non-Small Cell Lung Cancer (NSCLC) (audio)

Duration: 10 min

Tue Mar 31 2009

Series: PeerVoice Heart & Lung Audio

Episode: Checking In on Checkpoint Inhibitors: Current and Emerging Strategies for High PD-L1–Expressing Tumours in Advanced NSCLC

Duration: 29 min

Wed Jun 16 2021

Series: GRACEcast

Episode: Can we harness our immune system to fight NSCLC?

Duration: 9 min

Wed Jun 19 2013

Series: GRACEcast

Episode: Can we harness our immune system to fight NSCLC?

Duration: 9 min

Wed Jun 19 2013

Series: PeerVoice Clinical Pharmacology Video

Episode: Checking In on Checkpoint Inhibitors: Current and Emerging Strategies for High PD-L1–Expressing Tumours in Advanced NSCLC

Duration: 30 min

Wed Jun 16 2021

Series: PeerVoice Heart & Lung Video

Episode: Checking In on Checkpoint Inhibitors: Current and Emerging Strategies for High PD-L1–Expressing Tumours in Advanced NSCLC

Duration: 30 min

Wed Jun 16 2021